Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Causative agents of HAIs, stratified across HAI types

From: Incremental costs of hospital-acquired infections in COVID-19 patients in an adult intensive care unit of a tertiary hospital from a low-resource setting

Isolates

Total

PN

BSI

GI

UTI

SSI

(n, %)

Acinetobacter spp.

52 (43.0)

36 (65.5)

15 (28.3)

 

1 (50.0)

 

Coagulase-negative Staphylococcus

17 (14.0)

2 (3.6)

15 (28.3)

   

Enterococcus spp.

10 (8.3)

1 (1.8)

6 (11.3)

 

1 (50.0)

2 (40.0)

Pseudomonas aeruginosa

10 (8.3)

7 (12.7)

2 (3.8)

  

1 (20.0)

Clostridium difficile

6 (5.0)

  

6 (100.0)

  

Klebsiella spp.

5 (4.1)

2 (3.6)

3 (5.7)

   

Proteus mirabilis

5 (4.1)

2 (3.6)

1 (1.9)

  

2 (40.0)

Other Staphylococcal species

3 (2.5)

 

3 (5.7)

   

Staphylococcus aureus

3 (2.5)

2 (3.6)

1 (1.9)

   

Diphtheroids

3 (2.5)

1 (1.8)

2 (3.8)

   

Providencia spp.

3 (2.5)

2 (3.6)

1 (1.9)

   

Stenotrophomonas maltophilla

2 (1.7)

 

2 (3.8)

   

Achromobacter xylooxidans

2 (1.7)

 

2 (3.8)

   

Total

121

55

53

6

2

5

  1. PN - Pneumonia; BSI - bloodstream infection; GI - gastrointestinal infection; UTI - urinary tract infection; SSI - skin and soft tissue infection